Journal of International Reproductive Health/Family Planning ›› 2025, Vol. 44 ›› Issue (2): 116-120.doi: 10.12280/gjszjk.20240554
• Original Article • Previous Articles Next Articles
ZHAO Shu-ting, ZHOU Zhi-yi, XU Bo-qun()
Received:
2024-11-19
Published:
2025-03-15
Online:
2025-03-10
Contact:
XU bo-qun, E-mail: ZHAO Shu-ting, ZHOU Zhi-yi, XU Bo-qun. Analysis of Vaginal Microecological Characteristics in Gynecological Tumor Patients[J]. Journal of International Reproductive Health/Family Planning, 2025, 44(2): 116-120.
Add to citation manager EndNote|Ris|BibTeX
阴道微生态 | 阴道清洁度 | 优势菌 | 菌群多样性 | 菌群密集度 | 病原菌 |
---|---|---|---|---|---|
失衡 | Ⅲ~Ⅳ度 | 除乳杆菌外的其他菌 | Ⅰ级、Ⅳ级 | Ⅰ级、Ⅳ级 | 发现病原菌 |
平衡 | Ⅰ~Ⅱ度 | 乳杆菌 | Ⅱ~Ⅲ级 | Ⅱ~Ⅲ级 | 未发现病原菌 |
阴道微生态 | 阴道清洁度 | 优势菌 | 菌群多样性 | 菌群密集度 | 病原菌 |
---|---|---|---|---|---|
失衡 | Ⅲ~Ⅳ度 | 除乳杆菌外的其他菌 | Ⅰ级、Ⅳ级 | Ⅰ级、Ⅳ级 | 发现病原菌 |
平衡 | Ⅰ~Ⅱ度 | 乳杆菌 | Ⅱ~Ⅲ级 | Ⅱ~Ⅲ级 | 未发现病原菌 |
组别 | n | 年龄(岁) | BMI(kg/m2) |
---|---|---|---|
健康对照组 | 80 | 53.44±9.30 | 23.53±2.51 |
良性肿瘤组 | 94 | 52.14±10.93 | 23.94±2.55 |
恶性肿瘤组 | 58 | 53.26±10.61 | 24.08±2.40 |
F | 0.399 | 0.992 | |
P | 0.672 | 0.372 |
组别 | n | 年龄(岁) | BMI(kg/m2) |
---|---|---|---|
健康对照组 | 80 | 53.44±9.30 | 23.53±2.51 |
良性肿瘤组 | 94 | 52.14±10.93 | 23.94±2.55 |
恶性肿瘤组 | 58 | 53.26±10.61 | 24.08±2.40 |
F | 0.399 | 0.992 | |
P | 0.672 | 0.372 |
组别 | n | 乳杆菌减少 | 小杆菌增多 | 基底旁细胞增多 | 上皮细胞增多 | 白细胞增多 | 线索细胞阳性 |
---|---|---|---|---|---|---|---|
健康对照组 | 80 | 14(17.5) | 0(0.0) | 0(0.0) | 5(6.2) | 4(5.0) | 0(0.0) |
良性肿瘤组 | 94 | 53(56.4)a | 31(33.0)a | 6(6.4) | 11(11.7) | 32(34.0)a | 4(4.3)a |
恶性肿瘤组 | 58 | 49(84.5)ab | 18(31.0)a | 2(3.4) | 8(13.8) | 21(36.2)a | 11(19.0)ab |
χ2 | 62.918 | 32.776 | 5.428 | 2.377 | 25.322 | 18.912 | |
P | <0.001 | <0.001 | 0.052* | 0.311 | <0.001 | <0.001* | |
组别 | n | 孢子阳性 | 芽生孢子阳性 | 菌丝阳性 | 小球菌阳性 | 滴虫阳性 | |
健康对照组 | 80 | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
良性肿瘤组 | 94 | 2(2.1)a | 2(2.1)a | 1(1.1) | 1(1.1) | 1(1.1) | |
恶性肿瘤组 | 58 | 5(8.6)a | 5(8.6)a | 3(5.2) | 1(1.7) | 0(0.0) | |
χ2 | 7.429 | 7.429 | 4.346 | 1.494 | 1.494 | ||
P | 0.011* | 0.011* | 0.063* | 0.719* | 1.000* |
组别 | n | 乳杆菌减少 | 小杆菌增多 | 基底旁细胞增多 | 上皮细胞增多 | 白细胞增多 | 线索细胞阳性 |
---|---|---|---|---|---|---|---|
健康对照组 | 80 | 14(17.5) | 0(0.0) | 0(0.0) | 5(6.2) | 4(5.0) | 0(0.0) |
良性肿瘤组 | 94 | 53(56.4)a | 31(33.0)a | 6(6.4) | 11(11.7) | 32(34.0)a | 4(4.3)a |
恶性肿瘤组 | 58 | 49(84.5)ab | 18(31.0)a | 2(3.4) | 8(13.8) | 21(36.2)a | 11(19.0)ab |
χ2 | 62.918 | 32.776 | 5.428 | 2.377 | 25.322 | 18.912 | |
P | <0.001 | <0.001 | 0.052* | 0.311 | <0.001 | <0.001* | |
组别 | n | 孢子阳性 | 芽生孢子阳性 | 菌丝阳性 | 小球菌阳性 | 滴虫阳性 | |
健康对照组 | 80 | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | |
良性肿瘤组 | 94 | 2(2.1)a | 2(2.1)a | 1(1.1) | 1(1.1) | 1(1.1) | |
恶性肿瘤组 | 58 | 5(8.6)a | 5(8.6)a | 3(5.2) | 1(1.7) | 0(0.0) | |
χ2 | 7.429 | 7.429 | 4.346 | 1.494 | 1.494 | ||
P | 0.011* | 0.011* | 0.063* | 0.719* | 1.000* |
组别 | n | 清洁度异常 | pH值>4.5 | 菌群多样性异常 | 菌群密集度异常 | Nugent评分异常 | Donders评分异常 | 微生态失衡 |
---|---|---|---|---|---|---|---|---|
健康对照组 | 80 | 4(5.0) | 0(0.0) | 2(2.5) | 2(2.5) | 0(0.0) | 0(0.0) | 14(17.5) |
良性肿瘤组 | 94 | 39(41.5)a | 22(23.4)a | 15(16.0)a | 27(28.7)a | 39(41.5)a | 31(33.0)a | 62(66.0)a |
恶性肿瘤组 | 58 | 25(43.1)a | 55(94.8)ab | 21(36.2)ab | 29(50.0)ab | 30(51.7)a | 20(34.5)a | 55(94.8)ab |
χ2 | 34.874 | 143.176 | 27.912 | 41.628 | 53.487 | 34.453 | 87.580 | |
P | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | n | 清洁度异常 | pH值>4.5 | 菌群多样性异常 | 菌群密集度异常 | Nugent评分异常 | Donders评分异常 | 微生态失衡 |
---|---|---|---|---|---|---|---|---|
健康对照组 | 80 | 4(5.0) | 0(0.0) | 2(2.5) | 2(2.5) | 0(0.0) | 0(0.0) | 14(17.5) |
良性肿瘤组 | 94 | 39(41.5)a | 22(23.4)a | 15(16.0)a | 27(28.7)a | 39(41.5)a | 31(33.0)a | 62(66.0)a |
恶性肿瘤组 | 58 | 25(43.1)a | 55(94.8)ab | 21(36.2)ab | 29(50.0)ab | 30(51.7)a | 20(34.5)a | 55(94.8)ab |
χ2 | 34.874 | 143.176 | 27.912 | 41.628 | 53.487 | 34.453 | 87.580 | |
P | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
[1] | 潘钢芸. 妇科常见肿瘤的类型与特点[N]. 甘肃科技报,2024-04-22(06). |
[2] | 冯征, 郭勤浩, 朱俊, 等. 2023年度妇科恶性肿瘤治疗进展及展望[J]. 中国癌症杂志, 2024, 34(4):340-360. doi: 10.19401/j.cnki.1007-3639.2024.04.002. |
[3] | Bahuguna A, Dubey SK. Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics[J]. Biochim Biophys Acta Rev Cancer, 2023, 1878(5): 188956. doi: 10.1016/j.bbcan.2023.188956. |
[4] | 卿雪梅, 张勇. 阴道微生态失调之细菌性阴道病的研究进展[J]. 四川医学, 2024, 45(10):1160-1164. doi: 10.16252/j.cnki.issn1004-0501-2024.10.022. |
[5] | 向湘, 王妍, 陈佳乐, 等. 阴道菌群在妇科疾病中的研究进展[J]. 社区医学杂志, 2023, 21(10):540-544. doi: 10.19790/j.cnki.JCM.2023.10.11. |
[6] | 艾雯霞, 李东慧, 亓丁, 等. 细菌性阴道病最新诊断及治疗方案的研究进展[J]. 检验医学与临床, 2024, 21(9):1326-1331. doi: 10.3969/j.issn.1672-9455.2024.09.030. |
[7] | 丁丽, 罗晓华, 田野, 等. 阴道菌群与女性生殖道健康[J]. 河南预防医学杂志, 2021, 32(11):801-804,808. doi: 10.13515/j.cnki.hnjpm.1006-8414.2021.11.001. |
[8] | Xu H, Zhang S, Zhang B, et al. Vaginal colonization of Lactobacilli: Mechanism and function[J]. Microb Pathog, 2025,198:107141. doi: 10.1016/j.micpath.2024.107141. |
[9] | Avitabile E, Menotti L, Croatti V, et al. Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections[J]. Int J Mol Sci, 2024, 25(17):9168. doi: 10.3390/ijms25179168. |
[10] |
Bnfaga AA, Lee KW, Than L, et al. Antimicrobial and immunoregulatory effects of Lactobacillus delbrueckii 45E against genitourinary pathogens[J]. J Biomed Sci, 2023, 30(1):19. doi: 10.1186/s12929-023-00913-7.
pmid: 36959635 |
[11] | Ottinger S, Robertson CM, Branthoover H, et al. The human vaginal microbiota: from clinical medicine to models to mechanisms[J]. Curr Opin Microbiol, 2024,77:102422. doi: 10.1016/j.mib.2023.102422. |
[12] | 毛雪涛. 子宫肌瘤与肠道和生殖道菌群相关性的初步研究[D]. 长沙: 中南大学, 2023. |
[13] | Jacobson D, Moore K, Gunderson C, et al. Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer[J]. PeerJ, 2021,9:e11574. doi: 10.7717/peerj.11574. |
[14] | Yu T, Gao S, Jin F, et al. Characteristics of the vaginal microbiota and vaginal metabolites in women with cervical dysplasia[J]. Front Cell Infect Microbiol, 2024,14:1457216. doi: 10.3389/fcimb.2024.1457216. |
[15] |
Semertzidou A, Whelan E, Smith A, et al. Microbial signatures and continuum in endometrial cancer and benign patients[J]. Microbiome, 2024, 12(1):118. doi:10.1186/s40168-024-01821-0.
pmid: 38951935 |
[16] | Yang L, Li A, Wang Y, et al. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy[J]. Signal Transduct Target Ther, 2023, 8(1):35. doi: 10.1038/s41392-022-01304-4. |
[17] | 曾芳. 阴道用乳杆菌活菌胶囊联合抗菌治疗对细菌性阴道病患者阴道微生态及复发的影响[J]. 中国医学创新, 2024, 21(23):100-104. doi: 10.3969/j.issn.1674-4985.2024.23.024. |
[18] |
Lev-Sagie A, Goldman-Wohl D, Cohen Y, et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis[J]. Nat Med, 2019, 25(10):1500-1504. doi: 10.1038/s41591-019-0600-6.
pmid: 31591599 |
[1] | ZHANG Rong-xue, WANG Miao-miao, JIA Yuan-yuan, XUE Hui-ying. Study on the Vaginal Microbiota in Patients with Repeated Implantation Failure [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(2): 89-94. |
[2] | ZHANG Lu, GAO Cai-hong, BAO Hong-chu. The Correlation between Reproductive Tract Microbiome and Chronic Endometritis [J]. Journal of International Reproductive Health/Family Planning, 2023, 42(2): 167-171. |
[3] | YUAN Yu-qin, LI Hong-ying. Research Progress in Treatment of Primary Vaginal Cancer [J]. Journal of International Reproductive Health/Family Planning, 2023, 42(2): 172-176. |
[4] | XU Qian, CHENG Jiu-mei. A Case of Vaginal Foreign Body Retained for Ten Years in An Adult [J]. Journal of International Reproductive Health/Family Planning, 2022, 41(6): 472-475. |
[5] | LIN Kai-li, GUO Jie, REN Shu-qing, SONG Dian-rong, ZHANG Ji-wen, ZHAO Lin, LU Di, WANG Run-jing. A Preliminary Study on the Characteristics of Reproductive Tract Flora in Patients with Recurrent Spontaneous Abortion [J]. Journal of International Reproductive Health/Family Planning, 2022, 41(3): 177-183. |
[6] | CHENG Yang, ZHAO Min. Characteristics of Vaginal Flora in Patients with Recurrent Spontaneous Abortion [J]. Journal of International Reproductive Health/Family Planning, 2022, 41(3): 184-188. |
[7] | LIU Guang-pu, ZHAO Ling, WANG Sheng-pu, REN Wei-na, ZHANG Hui-xin. Intrapartum Factors Influencing Vaginal Birth after Cesarean [J]. Journal of International Reproductive Health/Family Planning, 2022, 41(3): 195-198. |
[8] | ZHANG Ming-wei, QI Qian-rong, XIE Qing-zhen. Relationship of Uterine Microbiota and Female Reproductive Healthy Diseases [J]. Journal of International Reproductive Health/Family Planning, 2022, 41(3): 214-218. |
[9] | WANG Li-na, YAO Li-jun, ZHANG Hui-ying. Genital Tract Microbiota and Endometrial Polyps [J]. Journal of International Reproductive Health/Family Planning, 2021, 40(6): 499-503. |
[10] | YU Xiao-feng, ZHENG Xiao-dan, CAI Xiao-hui. Two Cases Report of Angiomyofibroblastoma in the Vaginal Wall and Vulva, with A Mini Review [J]. Journal of International Reproductive Health/Family Planning, 2021, 40(3): 198-201. |
[11] | WEI Ying-ting, QIU Li-hua. Research Progress on the Correlation between the Outcome of Cervical HPV Infection and Vaginal Microbiome [J]. Journal of International Reproductive Health/Family Planning, 2021, 40(3): 252-255. |
[12] | CHEN Yu-ying, LIU Zi-wei, LAN Xiao-hui, CUI Man-hua, JIA Yan. Treatment of Primary Vaginal Adenocarcinoma by the Laparoscopic Surgery Combined with Vaginoplasty: a Case Report [J]. Journal of International Reproductive Health/Family Planning, 2021, 40(1): 32-34. |
[13] | DING Hui,LING Xiu-feng,LI Xiu-ling,ZHAO Chun,LU Ying,ZHANG Juan,XIE Qi-jun,CHEN Xiao-yan,WANG Pei. Analysis of Pregnancy Outcomes after Transvaginal Reduction of Triple Pregnancies with Monozygotic Twins [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(3): 198-201. |
[14] | REN Shu-qing,ZHANG Wei. Research Progress in Application of Reproductive Tract Microbiomes in Embryo Transfer [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(2): 158-162. |
[15] | GUO Zhe-xuan,LIAO Hui-hui,LI Yu,FENG Li. A Case Report of Double Uterus and Cervix with Vaginal Septum Misdiagnosed as Pelvic Mass [J]. Journal of International Reproductive Health/Family Planning, 2019, 38(2): 127-129. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||